Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1994-09-26
1996-06-18
Haley, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514653, 514654, 564 99, 564364, 564381, A61K 31135, C07C21127
Patent
active
055278302
ABSTRACT:
The invention relates to new drugs for augmenting perfusion pressure administered during cardiopulmonary resuscitation and other shock states. The compounds include phenylethanolamines and imidazolines, and fluorinated derivatives thereof, which act on adrenergic receptors in patients. The compounds of the invention enhance neurologic outcome and survival, and decrease ventricular dysrhythmias in patients suffering cardiac arrest and other shock states, relative to the outcomes, survival, and post defibrillation ventricular dysrhythmias in conventional therapy for use in resuscitation.
REFERENCES:
patent: 3660487 (1972-05-01), Larsen et al.
patent: 3976695 (1976-08-01), Kaiser et al.
Burger, A. et al, "Nuclear Substituted 3,4-Dihydroxyphenethylamines and Related Derivatives", J. Amer. Chem. Soc., vol. 78, No. 16, Aug. 1956, pp. 4419-4422.
Brown et al., "Adrenergic agonists during cardiopulmonary resuscitation", Resuscitation, vol. 19, 1990, pp. 1-16.
Lindner et al., "Comparison of Different Doses of Epinephrine on Myocardial Perfusion and Resuscitation Success During Cardiopulmonary Resuscitation in a Pig Model", Am. J. Emerg. Med., vol. 9, No. 1, 1991, pp. 27-31.
Gonzalez et al., "Dose-Dependent Vasopressor Response to Epinephrine During CPR in Human Beings", Ann Emerg Med, vol. 18:9, Sep. 1989, pp. 920-926.
Callaham et al., "A Randomized Clinical Trial of High-Dose Epinephrine and Norepinephrine vs Standard-Dose Epinephrine in Prehospital Cardiac Arrest", JAMA, vol. 268, No. 19, Nov. 18, 1992, pp. 2667-2672.
Brown et al., "The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine", Circulation, vol. 75, No. 2, Feb. 1987, pp. 491-497.
Brown et al., "Methoxamine versus epinephrine on regional cerebral blood flow during cardiopulmonary resuscitation", Crit. Care Med, vol. 15, No. 7, Jul. 1987, pp. 682-686.
Brown et al., "Effect of Standard Doses of Epinephrine on Myocardial Oxygen Delivery and Utilization During Cardiopulmonary Resuscitation", Crit. Care Med., vol. 16, No. 5, May 1988, pp. 536-539.
Brown et al., "Myocardial Oxygen Delivery/Consumption During Cardiopulmonary Resuscitation: A Comparison of Epinephrine and Pheylephrine", Ann Emerg Med, vol. 17:4, Apr. 1988, pp. 302-308.
Brown et al., "The Effect of Epinephrine Versus Methoxamine on Regional Myocardial Blood Flow and Defibrillation Rates Following a Prolonged Cardiorespiratory Arrest in a Swine Model", Am J Emerg Med., vol. 5, No. 5, 1987, pp. 362-369.
Goodman and Gilman (eds.), The Pharmacological Basis of Therapeutics, 5th ed., MacMillan Publishing Co., Inc., New York, 1975, p. 482.
Brown Charles G.
Miller Duane D.
Haley Jacqueline
The Ohio State University
LandOfFree
Drugs for the treatment of cardiac arrest and other shock states does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs for the treatment of cardiac arrest and other shock states, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for the treatment of cardiac arrest and other shock states will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-223300